International epidemiology of prostate cancer: geographical distribution and secular trends.
about
Laparoscopic versus open prostatectomy for the treatment of localised prostate cancerThe relationship between nutrition and prostate cancer: is more always better?An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-AnalysisEast meets West: ethnic differences in prostate cancer epidemiology between East Asians and CaucasiansTransrectal sonoelastography in the detection of prostate cancers: a meta-analysisAndrogenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic reviewEthnicity and the prostate cancer experience: a qualitative metasynthesisNutrition, dietary interventions and prostate cancer: the latest evidenceArachidonic acid metabolism in human prostate cancerRole of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate CancerApplication of vibro-acoustography in prostate tissue imagingThe Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells.A review of continuous vs intermittent androgen deprivation therapy: redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ″perpetual dispute″.Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich.3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: comparison of operative data and pentafecta rates: a single cohort study.ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer.The 4q27 locus and prostate cancer risk.Declining death rates reflect progress against cancer.Novel tools for prostate cancer prognosis, diagnosis, and follow-upProstate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosureDiagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalitiesCalorie restriction and cancer prevention: metabolic and molecular mechanisms.Apoptotic death of prostate cancer cells by a gonadotropin-releasing hormone-II antagonist.Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cellsVoltage-gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells.Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese miceLiving with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer.Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow upSelective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancerManagement of prostate cancer in port harcourt, Nigeria: changing patterns.The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, mi-R106b cluster expression, and PTEN dosage.Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.Key regulators in prostate cancer identified by co-expression module analysisPrediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreIncidence variation of prostate and cervical cancer according to socioeconomic level in the Girona Health Region.Second harmonic microscopic imaging and spectroscopic characterization in prostate pathological tissue.
P2860
Q24203782-FC87EB06-8647-405A-8679-B25ADC572032Q24604956-14A8316B-8E50-45B0-B044-1CD008D25B95Q26748679-2D3A9F0D-7E23-4C83-A445-B9E138501EDBQ26827438-06981D98-D3DD-4EF6-862C-CABC996B362EQ26851518-53EAE89E-54C4-4DFD-9D88-32DC60D47B7BQ26863665-A8698766-FB52-4992-9F91-2C704FB7354CQ28077224-2BD54D46-A753-41F8-8D90-50DA90E0D7F6Q28084566-11E8B76D-BABB-405A-BB32-4704837E0FF5Q28273154-3035DED0-0CAE-47BA-9374-183F7685CE82Q28554766-180E7C64-CCB0-4E9A-8DB3-3AC38D733702Q30443686-36828813-F0CA-4520-98D2-67B9094D1890Q30664167-C64C0FF5-AA14-43BE-AA38-DBE18BF038F9Q30780322-CD1ADE62-7592-4CF5-8BE5-245B4D30B444Q30906484-85E2E4E1-05CC-4961-92E3-60E34FE6C5F5Q30936063-47B2DD1D-CA5B-408F-98A3-F3AF0D2BBE48Q33354661-38B23B83-2094-457B-84D6-DB55D892E7B4Q33534461-46FECFFA-96B2-42F6-A504-F1CEBED929D7Q33541029-7A34BF75-0364-4675-B139-2B30BB91A8A3Q33625338-2D866EE6-C15E-4337-A742-03D962057FB3Q33642527-24DB40A9-F06F-4C07-A36A-BA50F1BF2976Q33669598-D1334A3D-5404-4C66-A7EF-B77FE3B3027EQ33693451-F03D672E-686D-464F-885A-DC3319DF9CDAQ33754466-6A5D27B0-C71D-4832-A847-04AC877B7C4EQ33762061-5A6FEE43-1F9C-4DCD-88BA-F0E451993C5AQ33778333-FDF969B8-84BD-49E2-A7A9-5648792B2B76Q33845027-5CA0C9FD-2378-4C8E-990D-59D4F3DC364CQ33856101-3BAA9402-5046-45D0-AFEB-5CA3C20CB9BEQ33870764-E82A5F0C-AEAB-4CE3-AD16-595F478D40EAQ33972182-5EC87512-189B-40BB-AB3F-060FB1FC91D4Q33995454-BB484E72-4E30-4344-91E5-A4EC8B470937Q34133206-AA24C9EA-B4F9-4497-8A93-2115EF604879Q34258976-A20280F3-1471-4869-9DA1-FA7CB6DEC1ADQ34427364-6109B9D4-27F2-46FB-B6A3-1337A0F58449Q34555654-05FA970F-ACCF-43D5-BE68-6D53F352EA7BQ34577999-3C5CE028-46EE-4D6A-A802-F1F80C191DA5Q34624597-B47E625F-8603-4BB8-9E1A-7ED37AB6C885Q34645685-0B588EA1-8015-4FBD-B4F4-013F7CB27B9EQ34861472-EBA473F2-BF77-4D87-828A-64BC581A23A1Q34875230-78B41AF5-02A4-4425-B796-ECEF4731F742Q34897758-7B4DE452-F1B9-41F3-93F1-04EE88383896
P2860
International epidemiology of prostate cancer: geographical distribution and secular trends.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
International epidemiology of ...... stribution and secular trends.
@ast
International epidemiology of ...... stribution and secular trends.
@en
International epidemiology of ...... stribution and secular trends.
@nl
type
label
International epidemiology of ...... stribution and secular trends.
@ast
International epidemiology of ...... stribution and secular trends.
@en
International epidemiology of ...... stribution and secular trends.
@nl
prefLabel
International epidemiology of ...... stribution and secular trends.
@ast
International epidemiology of ...... stribution and secular trends.
@en
International epidemiology of ...... stribution and secular trends.
@nl
P356
P1476
International epidemiology of ...... stribution and secular trends.
@en
P2093
Danny R Youlden
Lauren J Krnjacki
P2860
P304
P356
10.1002/MNFR.200700511
P577
2009-02-01T00:00:00Z